Current Funding Opportunities

2015 TCORS Pilot Project Program Announcement

The Yale Tobacco Center of Regulatory Science (TCORS) is offering funding for pilot projects to initiate research relating to understanding tobacco additives and modified risk tobacco products through behavioral, molecular, laboratory, pharmacological, epidemiological, and economic sciences that involves humans (both clinical & epidemiological research) and animals (basic research). We are particularly interested in studies of menthol, flavors, sweeteners, and e-cigarettes and studies using novel techniques.

Yale TCORS will fund 3-5 pilot projects at the level of $25,000 to $75,000 (direct costs only). The project must be completed in 1 budget year (9/1/15-8/31/16).

Letters of intent must:

• Be typewritten, double spaced, 12 point Times New Roman font with one inch margins

• Provide a descriptive title and the name and title of the PI and key personnel

• Include a 250-word summary of the proposed project, including specific aims, the time frame needed to achieve the stated aims, and a budget estimate

• Include a brief description of how the project will support the Yale TCORS goals or the 10 FDA Research Priorities.

• Include the applicant’s signature, address, telephone and fax numbers, and email address

• Include a NIH Biosketch (PHS 398-Rev. 08/12) with a Personal Statement of the PI’s experience and interest as it relates to the proposed project.

Convert your signed Letter of Intent into a PDF file and save it as “lastname_LOI_FY2015.”

Send your letter as an email attachment to tcors@yale.edu.

All letters must be received via email by December 5, 2014 by 4:00 pm. Facsimiles will not be accepted.

Learn More>>

Pancreatic Cancer Action Network Career Development Awards
The annual Pancreatic Cancer Action Network-AACR Research Career Development Awards represent a joint effort of the two organizations to encourage junior faculty who have completed their most recent doctoral degree or medical residency within the past eleven years to conduct pancreatic cancer research and establish successful career paths in the field. The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to pancreatic cancer.
Application Deadline: October 29, 2014

Learn More >> 
Alex's Lemonade Stand Foundation Innovation Grant
Do you have a novel idea that has potential for high impact on pediatric cancer patients? Does your idea, approach, or methodology have the potential to move your research and
the field in a new direction? ALSF's Innovation Grant provides seed funding for proof-of-concept proposals. The letter of intent must be approved in order to submit a full proposal. The award is up to $125,000 annually for two years.
Letter of Intent Deadline: November 3, 2014

Learn More >>
Melanoma Research Alliance Grants
Established Investigator Awards
Research Awards
Up to $125,000 per year for 2 - 3 years.
Special Opportunity: Bristol-Myers Squibb-MRA Established Investigator Awards in Immunotherapy
Up to $125,000 per year for 2 - 3 years to conduct projects focused on advancing the immunotherapies in melanoma.
MRA Pilot Awards
$50,000 per year for 2 years for potentially transformative pilot studies.
Special Pilot Opportunity: Society for Immunotherapy of Cancer-MRA Pilot Award
$50,000 per year for 2 years potentially transformative pilot studies in the area of immunotherapy. 
MRA Established Investigator Academic-Industry Partnership Awards
Up to $100,000 per year for 2 - 3 years.  Industry funds and/or in-kind support (e.g., reagents, clinical grade drugs, equipment, contract services) must match but may exceed MRA funds for the award period. Industry scientists may serve as co-investigators or collaborators, but may not be PIs. (Deadline: November 21, 2014)
Special Opportunity: Amgen-MRA Established Investigator Academic-Industry Partnership Award
In collaboration with Amgen, applications are solicited for preclinical or correlative laboratory studies related to the therapeutic potential of oncolytic virus immunotherapy in melanoma, alone or in combination with immune modulators (e.g., checkpoint inhibitors) or targeted therapies. Potential biomarkers of response in local and distant tumors and immune cell-type identification/evaluation in tumors and systemic changes related to oncolytic virus immunotherapy treatment are of interest. Mechanism of action studies using in vivo imaging or molecular techniques to differentiate direct versus immune-mediated effects are encouraged. Up to $100,000 per year for 2 to 3 years from MRA may be requested.Amgen funds will match MRA funds for the award period for a total combined award amount of up to $600,000.
MRA Young Investigator Awards
Investigators within 4 years of their first academic faculty appointment.
MRA Young Investigator Awards
Up to $75,000 per year for 3 years for translational research projects.
Special Opportunity: MRA Young Investigator Award in Dermatology
Seeking applications from dermatologist young investigators who remain actively engaged in patient care and are proposing studies in melanoma prevention, diagnosis/staging, and treatment.
MRA Team Research Awards
Special Opportunity: Bristol-Myers Squibb-MRA Team Science Awards in Immunotherapy: Awards for multidisciplinary teams of two or more established PIs, along with at least one Young Investigator to conduct projects with the potential to lead to transformative advances in melanoma immunotherapies. Up to $900,000 total over 2 - 3 years may be requested.
MRA Team Science Academic-Industry Partnership Awards
These awards are designed to facilitate progress via interactions between the academic and industrial research sectors in the team setting, and will be co-funded by MRA and an industrial collaborator whose involvement is essential to the project. Multidisciplinary teams of two or more established PIs will receive up to $500,000 total over 2 - 3 years from MRA to conduct projects supported by preliminary data. Each team must include at least one Young Investigator as a co-investigator. 
Application Deadline: November 21, 2014

Learn More >>

Lion Heart Fund for Cancer Research
The Lion Hearts are committed to finding a cure for cancer, and breast cancer in particular.  In keeping with this mission, they understand the value of funding bright young minds – providing them with pilot funding to kick-start high potential research projects, and/or supporting innovative work requiring bridge funding.  The Yale Cancer Center/Smilow Cancer Hospital, and particularly the Breast Center, are solid partners of the Lion Hearts and have a wealth of scientists and clinicians who are working hard towards the same goal.  The Lion Heart Fund for Cancer Research was developed in order to move this shared vision forward. 
Yale investigators are encouraged to submit proposals of innovative, high-potential projects requiring pilot funding.  Projects may be in any area of breast cancer research – basic, translational, clinical, outcomes and population science are all welcomed from any discipline or group of disciplines.  A committee, comprised of scientific/medical experts from Yale Cancer Center and dedicated Lion Hearts, will review the proposals and choose those to be funded.  Funding will be $20,000 for a one-year project.  Indirect costs are limited to 10%.  Funds may be used for salary support, equipment, materials etc.  It is expected that funds will be expended over one year; however, a one-time no-cost extension will be considered.  The number of projects funded will depend on the amount of funds raised the preceding year, but is estimated at 4 projects for the 2015 cycle.
Deadline for Proposals: November 15th, 2014
Learn More>>

The Terri Brodeur Breast Cancer Foundation 2015 Granting Process
The Terri Brodeur Breast Cancer Foundation http://www.terribrodeurbreastcancerfoundation.org/ is a nonprofit organization dedicated to providing critical funding to researchers investigating breast cancer therapies and new effective patient treatment options. Terri Brodeur, the Foundation’s namesake, was diagnosed with Stage 4 Breast Cancer in June 2003.

This award is intended to support PhD, MD/PhD and MD physician scientists at early stages of their research or clinical careers to enable them to develop as independent contributors in breast cancer research. The foundation seeks to fund broadly across all relevant disciplines and as such proposals can include basic, preclinical and clinical research. The award period is for two years with an interim renewal to occur upon successful completion of the first year and demonstrated progress toward proposal objectives. Stipends are $50,000 per year, with the intention that all funds are used for direct support of the grantee or applied to direct cost of the program. Exceptions to this policy should be anticipated by the applicant or sponsor institution.

Prospective applicants are expected to submit a research plan, pre-approved by their mentor or PI, to the foundation’s Scientific Advisory Committee. The research plan must be fundamentally sound and will include statements of:
(a) Scientific and technical merit of the research question;
(b) Design, methodology, and feasibility of the study;
(c) Relevance of the proposed research plan to the applicant’s career objectives;
(d) Significance of the proposed research to breast cancer prevention, control or treatment.

A preliminary application is mandatory for those applying for a 2015-16 fellowship grant and must be submitted by November 14th 2014. Proposals should be sent electronically to the address given below:
Attn: Dr. Nicholas A. Saccomano, Ph.D.

Learn More>>


Free to Breathe Issues Request for Proposals for Lung Cancer Research
Free to Breathe, a partnership of lung cancer survivors, advocates, researchers, healthcare professionals, and industry leaders united in the belief that every person with lung cancer deserves a cure, has issued a Request for Proposals for research projects focused on preventing or stopping lung cancer metastasis.
Grants of up to $600,000 over three years will be awarded in support of innovative, high-impact lung cancer research that leads to clinical translation (e.g. clinical trial) by the end of the award period. The partnership is particularly interested in proposals that include interdisciplinary teams and two or more principal investigators; collaborations with industry partners (PIs must be employed at a nonprofit entity such as an academic or research institution); access to existing patient samples or data, especially tissue from metastatic sites; studies that include mechanistic investigations into the underlying causes of metastasis; studies that are distinct research components of new or existing clinical trials; and/or novel approaches for preventing brain metastasis.

Application Deadline: November 7, 2014

Learn More >> (PDF)

NCCN Research Grant
National Comprehensive Cancer Network® (NCCN®) is pleased to announce that it has received a $2 million research grant from Boehringer Ingelheim Pharmaceuticals, Inc. to support NCCN investigator initiated clinical studies of volasertib in the treatment of aggressive lymphoid malignancies. A Request for Proposals (RFP) is available by clicking the link below. The document clearly outlines the scope and process that will be followed for the submission of proposals.  In brief, investigators are asked to submit short proposals detailing proposed studies. The overall aim of this RFP is to develop innovative studies of volasertib in the treatment of aggressive lymphoid malignancies including acute lymphoblastic leukemia, aggressive lymphoma histologies (including Hodgkin lymphoma), and multiple myeloma. It is hoped that the proposals submitted in response to this RFP will prove useful in guiding the further development of volasertib. Collaborative studies between NCCN Member Institutions are encouraged.
Proposals are due by 5:00 PM EDT, Thursday, October 30, 2014. Electronic submission of proposals is available by clicking the link provided below. For additional information, please contact Doreen Walker, Administrative Assistant, Oncology Research Program, at 215.690.0565 or via e-mail at Walker@nccn.org.

Learn More>>


Center for Cancer Research Clinical Investigator Development Program
The Center for Cancer Research (CCR), a Division of the National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), is pleased to announce its annual call for applications for Clinical Investigator Development Program (CIDP). This is an exciting training opportunity intended for physicians interested in dedicating their careers to clinical research. Candidates may be U.S. citizens, permanent residents or possess (or be eligible for) the appropriate work visa and must have successfully completed subspecialty training at a U.S.-accredited institution in appropriate fields.
Application Deadline: October 30, 2014
Learn More >>

YCC/SCH Grants for Small Projects to Improve Patient Care

Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven are pleased to announce a new program to fund small projects to improve patient care at Smilow Cancer Hospital. Monies for this program have come through our “Closer to Free” fund. Any employee at Smilow Cancer Hospital who develops a small project may apply by submitting an application for review. Projects can range from a patient education program to stress management for staff. In order to be eligible, the employee must be sponsored by a current Cancer Center Member. A listing of active cancer center members is on the web site.

Grant Details

Amount: $2,500 to $5,000 each

Eligibility: Employees of Smilow Cancer Hospital at Yale-New Haven

Sponsorship: Member of Yale Cancer Center

Application: Limited to 3 pages, typed, double spaced; plus budget with justification (3 copies)

- Application sheet: Project Due Date

- Project Description

- Budget

- Budget Justification

Submit to Renee Gaudette: renee.gaudette@yale.edu

For questions, contact Dr. Ruth McCorkle by email: ruth.mccorkle@yale.edu


Damon Runyon Physician-Scientist Training Award Overview
Physician-scientists who are both clinically trained and expert researchers are essential to the successful translation of scientific discovery into more effective patient therapies. They have the unique capacity to blend their insights from treating patients and working in the laboratory in a way that enables and accelerates medical advances. However, the pipeline of physician-scientists is dwindling. The decline in this vital cadre of cancer researchers is occurring at a time when cancer research holds the greatest promise of improving survival and quality of life among cancer patients. A growing shortage of physician-scientists means that major laboratory research discoveries will progress to patient application ever more slowly. If the shortage continues unabated, some may not reach patient application at all, thus presenting a crisis in cancer research.
The award will be for a period of four years. Funding will be allocated to the awardee’s institution each year for the support of the scientist.  Funds are to be used for stipend and/or research expenses. No part of this grant can be used for indirect costs or institutional overhead.
Year 1 - $100,000
Year 2 - $110,000
Year 3 - $120,000
Year 4 - $130,000
(Total $460,000)*
*Awardees still in their ACGME training years will be paid an award amount commensurate with their institutional salary based on post-graduate year (i.e., PGY6 salary). Upon completion of that training, the award amount will increase to $100,000, with a $10,000 increase for each subsequent year of the Damon Runyon award.

Application Deadline: December 1, 2014
Learn More>>

Ruth McCorkle Oncology Advanced Practice Provider Award

This annual recognition from Yale Cancer Center/Smilow Cancer Hospital will be presented at the YCC Conclave on Monday, November 24, 2014. 
Please consider nominating yourself or a colleague for this award.  It is a unique opportunity to recognize the contributions of our APP colleagues who contribute so much to oncology patient care.
Nominations will be evaluated and the recipient selected by the YCC/Smilow Leadership.  Please submit no later than Friday, October 24, 2014.

Nomination Form>> 


Women’s Research Center at Yale Pilot Project Program

Now in its 17th year, Women’s Health Research at Yale has provided $4.6 million in Pilot Project Program funding, and the results of these seed grants to Yale researchers have generated more than $56 million in new external funding for Yale laboratories and clinical research settings.

Women’s Health Research at Yale 2014-2015 Pilot Project Program offers the following research funds:
·       Pilot Project Awards: Up to $35,000 over one or two years for research designed to meet a clear need in advancing women’s health.
·        Wendy U. & Thomas C. Naratil Pioneer Award: Up to $50,000 in funding over one or two years to initiate new, highly inventive research or to achieve a major breakthrough in ongoing research where funding is needed to achieve its aims. 

All studies selected for funding must demonstrate innovative approaches to major women’s health challenges, and describe a clear path to implementation for clinical or public health benefit.
The projects funded by Women’s Health Research at Yale span a wide array of research topics on gender-related health conditions.  For a list of topics, please visit the Research Findings section of our website -

For both awards, Letters of Intent are due: Wednesday, October 29, 2014 (noon)
All full-time Yale faculty members are eligible to apply.

Learn More>>